Insider Transactions in Q3 2025 at Blade Air Mobility, Inc. (BLDE)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2025
|
Amir Cohen Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,707
-3.57%
|
$14,828
$4.0 P/Share
|
|
Sep 10
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
34,018
-2.85%
|
$136,072
$4.0 P/Share
|
|
Sep 10
2025
|
William A. Heyburn Co-CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
35,348
-2.64%
|
$141,392
$4.0 P/Share
|
|
Sep 10
2025
|
Scott M Wunsch CEO, Trinity Air Medical |
SELL
Payment of exercise price or tax liability
|
Direct |
2,378
-0.78%
|
$9,512
$4.0 P/Share
|
|
Aug 29
2025
|
Robert S Wiesenthal Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,607
+0.76%
|
-
|
|
Aug 29
2025
|
Andrew Lauck Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,844
+8.31%
|
-
|
|
Aug 29
2025
|
Amir Cohen Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,844
+10.25%
|
-
|
|
Aug 14
2025
|
Scott M Wunsch CEO, Trinity Air Medical |
BUY
Grant, award, or other acquisition
|
Direct |
22,365
+6.85%
|
-
|
|
Aug 07
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
23,945
+1.97%
|
$0
$0.18 P/Share
|
|
Aug 06
2025
|
Robert S Wiesenthal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
282,470
+4.39%
|
$0
$0.18 P/Share
|
|
Aug 06
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,500
+1.72%
|
$0
$0.18 P/Share
|
|
Aug 04
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
SELL
Open market or private sale
|
Direct |
47,995
-4.01%
|
$191,980
$4.94 P/Share
|
|
Aug 04
2025
|
William A. Heyburn Co-CEO and CFO |
SELL
Open market or private sale
|
Direct |
46,918
-3.38%
|
$187,672
$4.94 P/Share
|
|
Aug 01
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
81,071
-6.34%
|
$243,213
$3.99 P/Share
|
|
Aug 01
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
160,714
+11.17%
|
-
|
|
Aug 01
2025
|
Robert S Wiesenthal Director |
SELL
Payment of exercise price or tax liability
|
Direct |
136,263
-2.27%
|
$408,789
$3.99 P/Share
|
|
Aug 01
2025
|
Robert S Wiesenthal Director |
BUY
Grant, award, or other acquisition
|
Direct |
246,429
+3.94%
|
-
|
|
Aug 01
2025
|
Eric Affeldt Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,534
+17.63%
|
-
|
|
Aug 01
2025
|
Amir Cohen Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,426
-14.37%
|
$46,278
$3.99 P/Share
|
|
Aug 01
2025
|
Amir Cohen Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,143
+23.04%
|
-
|
|
Aug 01
2025
|
Edward M Philip Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,534
+13.18%
|
-
|
|
Aug 01
2025
|
Andrew Lauck Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,534
+23.02%
|
-
|
|
Aug 01
2025
|
Reginald Love Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,534
+20.73%
|
-
|
|
Aug 01
2025
|
Kenneth B Lerer Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,534
+17.63%
|
-
|
|
Aug 01
2025
|
Susan M Lyne Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,534
+15.95%
|
-
|
|
Aug 01
2025
|
William A. Heyburn Co-CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
76,177
-5.2%
|
$228,531
$3.99 P/Share
|
|
Aug 01
2025
|
William A. Heyburn Co-CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
139,286
+8.69%
|
-
|
|
Aug 01
2025
|
John Borthwick Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,534
+14.84%
|
-
|